We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
-1.27%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$283B
AUM Growth
+$27.4B
Cap. Flow
+$30.5B
Cap. Flow %
10.78%
Top 10 Hldgs %
36.77%
Holding
11,338
New
1,654
Increased
4,102
Reduced
3,903
Closed
1,507

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 2.35%
2 Technology 1.76%
3 Financials 1%
4 Communication Services 0.83%
5 Healthcare 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRPB.WS
9426
DELISTED
CC Neuberger Principal Holdings II Redeemable warrants, each whole warrant exercisable for one Class
PRPB.WS
$55K ﹤0.01%
54,395
+79
+0.1% +$92
DMYQ.WS
9427
DELISTED
dMY Technology Group, Inc. IV Redeemable warrants, each whole warrant exercisable for one share of C
DMYQ.WS
$55K ﹤0.01%
29,080
-54
-0.2% -$85
FRMM
9428
PUT
Forum Markets
FRMM
$79.5M
$54K ﹤0.01%
3
-1
-25% -$27.3K
ENTX icon
9429
Entera Bio
ENTX
$141M
$54K ﹤0.01%
+11,563
New +$59.3K
PLX icon
9430
Protalix BioTherapeutics
PLX
$198M
$54K ﹤0.01%
40,949
+9,284
+29% +$14.1K
CAPR icon
9431
CALL
Capricor Therapeutics
CAPR
$237M
$53K ﹤0.01%
13,100
-10,300
-44% -$46.9K
MYSZ icon
9432
My Size
MYSZ
$1.88M
$53K ﹤0.01%
194
+62
+47% +$15.9K
PGEN icon
9433
PUT
Precigen
PGEN
$2.59B
$53K ﹤0.01%
10,700
-4,900
-31% -$28.2K
PLUR icon
9434
Pluri
PLUR
$19.6M
$53K ﹤0.01%
2,503
-5,176
-67% -$133K
HLAHW
9435
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Warrant
HLAHW
$53K ﹤0.01%
66,600
NDACW
9436
DELISTED
NightDragon Acquisition Corp. Warrants to purchase Class A common stock
NDACW
$53K ﹤0.01%
+62,101
New +$72.2K
CTXR icon
9437
CALL
Citius Pharmaceuticals
CTXR
$18.7M
$52K ﹤0.01%
+1,024
New +$51.4K
GERN icon
9438
Geron
GERN
$949M
$52K ﹤0.01%
37,731
-75,223
-67% -$100K
KNDI
9439
Kandi Technologies Group
KNDI
$65.5M
$52K ﹤0.01%
+11,590
New +$58.6K
SGLY icon
9440
Singularity Future Technology
SGLY
$6.16M
$52K ﹤0.01%
+164
New +$64.5K
SLACW
9441
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$52K ﹤0.01%
62,880
TYME
9442
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$52K ﹤0.01%
50,628
+24,487
+94% +$27K
CYCN icon
9443
Cyclerion Therapeutics
CYCN
$16.7M
$51K ﹤0.01%
+830
New +$54.3K
VLDRW
9444
DELISTED
Velodyne Lidar, Inc. Warrants
VLDRW
$51K ﹤0.01%
38,457
-148
-0.4% -$301
NAACW
9445
DELISTED
North Atlantic Acquisition Corporation Warrant
NAACW
$51K ﹤0.01%
67,383
+190
+0.3% +$179
HTPA.WS
9446
DELISTED
Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HTPA.WS
$51K ﹤0.01%
33,738
-216
-0.6% -$242
OACB.WS
9447
DELISTED
Oaktree Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share
OACB.WS
$51K ﹤0.01%
57,144
+30
+0.1% +$32
CTIC
9448
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$51K ﹤0.01%
+17,319
New +$47.2K
HLX icon
9449
PUT
Helix Energy Solutions
HLX
$1.41B
$50K ﹤0.01%
13,000
+2,800
+27% +$11.5K
LTRYW icon
9450
Sports Entertainment Gaming Global Corp Warrants
LTRYW
$644
$50K ﹤0.01%
24,695
+13,507
+121% +$25.6K

Similar funds

Jane Street's Q3 2021 Portfolio in Review

As of Q3 2021, Jane Street held 11,338 positions worth $283B, up 11% from $256B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jane Street deployed $30.5B of net new capital in Q3 2021, opening 1,654 new positions and adding to 4,102 existing holdings. Its largest new stake was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.3% of assets, down from 2.5% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares MBS ETF, an estimated $1.01B trimmed.

  • Jane Street's largest Q3 2021 buy was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.
  • Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $1.64B increase.
  • Jane Street's biggest Q3 2021 reduction was iShares MBS ETF, cutting an estimated $1.01B.
  • Jane Street fully exited Vanguard Tax-Exempt Bond Index Fund in Q3 2021, selling an estimated $338M.
  • Jane Street's ten largest holdings make up 37% of its $283B portfolio in Q3 2021.
  • Jane Street opened 1,654 new positions and closed 1,507 in Q3 2021.
  • Jane Street's portfolio value rose 11% quarter-over-quarter to $283B.

Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.